None of the presently known mycoplasmal respiratory diseases of animals offers a model system closely resembling chronic bronchitis or pulmonary emphysema. The only animal disease with clinical and pathological similarities to human emphysema is the emphysema seen in horses. This is a very interesting model and would probably be useful for clinical evaluation and manipulation, but it is not going to be a useful model for the study of the etiological factors involved since this disease is rarely diagnosed until it becomes well advanced.
In my opinion, the rat model offers the most promising possibilities in this area. The rat can develop chronic lung disease. Indeed these are of the commonest lesions found in old rats: pneumonias, bronchitis, and bronchiectasis. Although it is not exactly the same disease you see in the human patient, it has some characteristics in the course of development that are closely related.
This disease in rats appears to have a multiple etiology. The factor of age plays a very significant role; the advanced lesions are characteristically seen in old rats. Mycoplasma (M. pulmonis and possibly other species) definitely plays a part in the disease. Although there seems to be some argument about its actual nature and significance, the virus described by Dr. Nelson' of the Rockefeller Institute also apparently plays some part in this disease. In addition, the rat is an animal that can be and already is being used for chemical and other environmental injury studies.
These facts would suggest that a logical extension of our knowledge would involve combined studies of the effects of aging, injury, and multiple infectious agents singly and in various combinations on the respiratory tracts of rats. The rat has a relatively short life span and is easy to maintain. The most important factor in the choice of the rat is that this animal can be, given proper conditions, produced free of respiratory tract infection. This is a crucial factor in determining the possible etiological relationships and interrelationships of any infectious agents to chronic respiratory disease, as will be evident from our later discussion on avian respiratory disease.
* Professor of Avian Diseases.
The organization and development of such a rat model system will be no simple exercise but will require a careful correlated research project employing laboratory animal disease specialists, microbiologists, virologists, experimental pathologists and physiologists operating in concert. It would also require adequate isolation and production facilities for a reasonably large rat population. To offset these difficulties it should be pointed out that most of the basic technical procedures and information necessary to carry out such a project are already available.
To illustrate the feasibility and the problems involved in studying a respiratory disease with multiple etiological factors, I should like to discuss chronic respiratory disease in chickens. This disease is quite different from the human diseases we are discussing at this meeting.
Chronic respiratory disease of chickens (Mycoplasma gallisepticum infection) is not really a chronic disease. That is, it is not a progressive disease. It will affect the animal for a relatively long period of time-several months-but it tends to heal spontaneously if no other etiological agents intervene.
Thus with this avian model we must differentiate between two diseases. First, the disease caused by M. gallisepticum alone is a superficial infection, primarily of the upper respiratory tract and trachea with minimal lesions in the lower respiratory tract. This disease is usually rather mild and the lesions tend to heal over the course of five to six weeks. The organisms may persist in the respiratory tract for long periods of time and carriers have been demonstrated for as long as six months. Only rarely will the organism invade the joints or the central nervous system. The second disease that was caused by M. gallisepticum infection complicated with Escherichia coli infection was characterized by a severe mucopurulent to fibrinopurulent pericarditis, perihepatitis, and peritonitis. This disease caused severe mortality in our chicken flocks and extensive losses due to condemnation of poultry carcasses at slaughtering plants.
Mycoplasma gallisepticum is spread primarily by egg transmission. Foci of infection in the periovarian region and in the upper portion of the oviduct lead to surface contamination of the ovule or egg yolk as it drops into the oviduct. During the courses of embryonic development the organisms multiply and invade the embryo. At the time the chick hatches the infection may be so severe that it causes grossly visible lesions in the trachea, lungs, and air sacs which may cause significant levels of late embryonic mortality. More often the infection is less severe and slowly develops in the hatched chicks and spreads by contact to the pen mates. The rate at which such contact infection occurs is markedly increased by various respiratory virus infections such as Newcastle disease or infectious bronchitis.
It should be noted that such egg transmission of M. gallisepticum characteristically occurs at a very low rate. Under field conditions, the rate may be as low as one infected egg per thousand. Since chickens are usually grown in large populations (five, ten, or twenty thousand to a group) even infection rates as low as this will insure that almost all of our groups of chickens will contain some MG at the time they start their growing cycle. This will normally spread relatively slowly from bird to bird, but eventually will get into the entire group of birds. It is at this point that the respiratory viruses, either as natural infections or in the form of live-virus vaccines act to accelerate the spread of MG infection.
Once the MG infection is present, the infected birds seem to undergo some alteration in the characteristics of their respiratory tract surfaces that increases their susceptibility to secondary E. coli infection. The nature of these alterations has not as yet been determined. Present evidence would suggest that the E. coli are present in the bird and its environment rather commonly but that they are unable to cause any significant damage if the animals have not been infected previously with MG. The nature of these interrelationships can best be demonstrated by describing an experiment that we carried out several years ago. 2 Groups of "specific pathogen-free" chickens were infected with Mycoplasma gaclil septicum, pathogenic serotypes of E. coli and infectious bronchitis virus. Each of these agents was used individually and in various combinations. The experimental design and results are presented in Table 1 .
Previous work by Dr. W. B. Gross? of the Virginia Agricultural Experiment Station had established the fact that a combination of MG and E. coli would produce under experimental conditions the same severe disease we saw in the field. This was especially true if the mycoplasma was given first and the E. coli later. Our particular interest was in trying to determine the clinical and epidemological significance of this relationship. For this purpose large groups of contact controls were placed in the same isolation pens with each of the infected groups. Because of the relatively slow rate of spread of M. gallisepticum, half of the contact controls in the pens where this organism was used were experimentally inoculated with MG. Except for these two groups, all of the agents used in these experiments had to spread by natural contact infection to the controls.
The data in Table 1 clearly confirmed the previous data on mycoplasma-E. coli relationships in inoculated birds. Even more important, however, was the data secured from the contact controls. The complete lack of spread of the pure E. coli infection from the inoculated to the controls was a marked contrast to the relatively high rate of lesions produced in the groups given MG in addition to E. coli. Also significant is the greater susceptibility of the contacts prepared by MG inoculation to the negative contacts.
This experiment provided good evidence not only that MG played a significant part in the susceptibility of chickens to E. coli, but also markedly influenced the spread of the disease within the flock. All of this work was, of course, predicated on the fact that we were able to start our experiment with groups of chickens free of all of these agents. This is one reason I feel that the rat model, which could also be produced free of all relevant infectious agents, is an important one to consider.
Field evidence suggests that such chronic avian respiratory infections as those described above are influenced to some degree by noxious environmental factors. Overcrowding, poor poultry house ventilation with consequent high levels of dust and ammonia fumes and similar factors tend to result in higher respiratory disease losses.
It should be re-emphasized at this time that none of the mycoplasmal respiratory diseases of animals studied up to now really produces a typical progressive respiratory infection.
Animal mycoplasmoses I FABRICANT The mycoplasmal lesions heal readily and completely or leave chronic encysted or sequestered areas. When chronic lesions do occur they are usually associated with secondary bacterial infections. However, useful information on the potential long-term pathological effects of mycoplasmal respiratory disease probably could be secured by carefully planned experiments with M. gallisepticum in turkeys and with M. suipneumoniae in pigs maintained free of contaminating secondary infections.
